Sat. Feb 24th, 2024

Researchers from the University of British Columbia in Vancouver reported a significantly reduced risk for cardiovascular events among patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) who are on hydroxychloroquine.

By Owner

Related Post

Social media & sharing icons powered by UltimatelySocial

Enjoy this blog? Please spread the word :)